PURPOSE: Cisplatin-based combination chemotherapy is considered standard treatment for
advanced/recurrent cervical carcinoma; however, the majority of patients do not respond …

OBJECTIVE.: Cisplatin-based combination therapy produces higher response rates and
improved survival, in comparison to single-agent cisplatin in the treatment of cervical cancer …

OBJECTIVES: The aim of this study was to evaluate the effect of number of chemotherapy
cycles and other clinical and pathologic factors on progression-free (PFS) and overall …

Objective A recent randomized trial demonstrated that concurrent chemoradiotherapy
(CCRT) with weekly cisplatin and gemcitabine, followed by two adjuvant cycles of cisplatin …

PURPOSE: To compare the treatment and outcomes of cervical cancer patients treated with
concurrent chemoradiotherapy (CT-RT) in a multi-institutional trial or as standard care …

OBJECTIVE: To review the clinical trial experience with chemotherapy for patients with
primary Stage IVB, persistent and recurrent cervical cancer. METHODS: PubMed and …

When cervical cancer is beyond curative treatment with surgery or radiation therapy, the
prognosis is poor and palliation is the primary objective. Early prospective studies identified …

Objectives: The purpose of this study was to evaluate the activity and toxicity of carboplatin
and paclitaxel combination in advanced or recurrent carcinoma of the cervix. Methods: Fifty …

OBJECTIVES: The objectives were to determine the acute toxicities of concurrent
carboplatin and radiation therapy in the primary treatment of cervix cancer and to ascertain …

PURPOSE: To compare gemcitabine and cisplatin (GC) with cisplatin (C) concurrent with
radiotherapy in International Federation of Gynecology and Obstetrics Stage IB2, IIA, and IIB …